CHARACTERISTIC AND MANAGEMENT FOURNIER’S GANGRENE IN ARIFIN ACHMAD REGIONAL GENERAL HOSPITAL OF RIAU PROVINCE

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

PDF
Published 2020-07-20
Zuhirman Zamzami Indra Jaya Muhammad Adan Yashar Maria Zalena

Abstract

Objective: To evaluate the characteristic and the management of Fournier’s gangrene. Material & Methods: We reviewed medical records of Fournier’s gangrene patients including age, etiology, invasion of bacteria, underlying disorders, clinical symptom, radiology and laboratory findings, management, and complication in Arifin Achmad General Hospital, Pekanbaru, Riau Province, in January 2012–December 2017. Statistical analysis of univariate was used. Approval of the study was obtained from the Ethical Review Board for Medicine and Health Research, Medical Faculty, University of Riau. Results: There were 19 patients in the study. The result showed that Fournier’s gangrene cases occurred mostly in age 56-65 year old age group in 8 (42.1%) patients. The etiology was from urogenital cause in 15 (78.9%) patients. Most invasion bacteria was Acinetobacter baumannii in 5 (26.3% ) patients. The most underlying disorder was elderly age in 10 (5.6%) patients. The most frequent symptom was puss on the scrotal in 10 (52.6%)patients. The most laboratory examination was puss bacterial culture in 14 (73.7%) patients. The most frequent treatment for Fournier’s gangrene was initial and preoperative management in 19 (100%) patients. The acute complication of Fournier’s gangrene was sepsis in 5 (26.3%) patients. Conclusion: Fournier’s gangrene occurred mostly in elderly age in which Acinetobacter baumannii was the most invasion bacteria and sepsis was the most complication.


##plugins.themes.bootstrap3.article.details##

Keywords

Elderly age, puss in the scrotum, urogenital

References

Purnomo BB. Fournier’s Gangrene. Dasar-dasar urologi. Edisi Kedua. Jakarta: Sagung seto; 2007. p. 76-77.

Heyns CF. Fournier’s Gangrene. In Hohenfellner M, Santucci SA, editors. Emergencies and Urology. London: Springer-Verlag Berlin Heidelberg; 2006. p. 50-60.

Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack CD, Wessells H. Fournier’s gangrene: Population based epidemiology and outcomes. J Urol. 2009; 181(5): 2120- 6.

Setiawan F, Novianti R, Wicaksono. Fournier’s gangrene. CDK-205. 2013; 40(6): 432-5.

Li YD, Zhu WF, Qiao JJ, Lin.JJ. Enterostomy can decrease the mortality of patients with Fournier Gangrene. World J Gastroenterol. 2014; 20(24): 7950-4.

World Health Organization. 2016. Global Report on Diabetes. http://www.who.int/iris/handle/10665/204871.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimate for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5): 1047-53.

Kementerian Kesehatan RI.2014. http://www.depkes.go.id.

Sudiono J. Komposisi sistem imun. Sistem kekebalan tubuh. Jakarta: EGC; 2014. p. 38-9.

Scârneciu I, Maxim I, Lupu S, Scârneciu CC. Fournier's Gangrene: Predisposing factors, emergency management and mortality rate. Medical Sciences. 2013; 6(55): 77-80.

Pubmed. Scrotal pyocele: uncommon urologic emergency. https://www.ncbi.nlm.nih.gov/m/pubmed/22797360/.

Neary E. A case of Fournier's gangrene. TSMJ. 2005; 6: 68-73.

World Health Organization. 2011. Report on the burden of endemic health care-associatedd infection worldwide. http://www.who.int/iris/handle/10665/80135.

Soedarto. Infeksi nosokomial di rumah sakit, edisi pertama. Jakarta: Sagung Seto; 2016. p. 31.

Kumar V, Abbas AK, Fausto N. Hypertensive vascular disease. In: Robin and Cotran Pathologic Basis of Disease, 7th edition. Philadelphia: Elsevier sanders; 2005. p. 528-9.

Ashrafuzzaman, Bhattacharjee A, Rahman M. Fournier’s gangrene: approaches to the diagnosis and treatment. Delta Med Col J. 2017; 5(2): 68-75.

Üreyen O, Acar A, Gökçelli U, Atahan MK, İlhan E. Usefulness of FGSI and UFGSI scoring systems for predicting mortality in patients with Fournier’s gangrene. TJTES. 2017; 23(5): 389-94.

Ochoa GJ, Lira C-D, Macias V, Soler LM, Scott R. Usefulness of Fournier's gangrene severity index: a comparative study. Rev Mex Urol. 2010; 70(1): 27-30.

Benjelloun EB, Souiki T, Yakla N, Ousadden A, Mazaz K, Louchi A. Fournier’s gangrene: Our experience with 50 patients and analysis of factors affecting mortality. World Journal of Emergency Surgery. 2013; 8: 13.

Smith GL, Bunker CB, Dinneen M. Fournier’s gangrene. BJU. 1998; 81: 347-55.

Kumar A, Thakur M. Fournier’s gangrene-presentation and outcome. IJSS Journal of Surgery. 2016; 2(6): 66-71.

Sudiono J. Strategi pertahanan tubuh.Dalam: Junowo L editor. Sistem kekebalan tubuh. Jakarta: EGC; 2014. p. 6-7.

Efem, SEE. The features of aetiology of fournier’s gangrene. Post Grad Med J. 1994; 70: 568-71.

Medscape. Treating severe soft tissue infection: how and what I do. http://www.medscape.com/view/article/5.

Section
Articles
Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University